Qsemble Capital Management LP Takes $3.34 Million Position in HCA Healthcare, Inc. $HCA

Qsemble Capital Management LP purchased a new position in HCA Healthcare, Inc. (NYSE:HCA) in the fourth quarter, Holdings Channel reports. The fund purchased 7,158 shares of the company’s stock, valued at approximately $3,342,000.

A number of other institutional investors have also made changes to their positions in the company. Viking Global Investors LP raised its position in shares of HCA Healthcare by 58.5% during the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after acquiring an additional 690,773 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its holdings in shares of HCA Healthcare by 4,545.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock worth $309,686,000 after purchasing an additional 649,058 shares during the period. Danske Bank A S acquired a new position in shares of HCA Healthcare in the 3rd quarter valued at about $115,530,000. Zurich Insurance Group Ltd FI raised its stake in HCA Healthcare by 3,755.9% during the third quarter. Zurich Insurance Group Ltd FI now owns 269,912 shares of the company’s stock worth $115,036,000 after acquiring an additional 262,912 shares during the period. Finally, Mondrian Investment Partners LTD acquired a new position in HCA Healthcare in the third quarter valued at approximately $106,605,000. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Price Performance

NYSE HCA opened at $422.68 on Friday. The company’s 50 day simple moving average is $478.74 and its 200 day simple moving average is $485.84. The firm has a market capitalization of $93.77 billion, a PE ratio of 14.54, a P/E/G ratio of 1.34 and a beta of 1.18. HCA Healthcare, Inc. has a 12 month low of $330.00 and a 12 month high of $556.52.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. During the same period in the previous year, the firm earned $6.45 earnings per share. HCA Healthcare’s revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be given a $0.78 dividend. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.7%. HCA Healthcare’s payout ratio is 10.73%.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on HCA. Weiss Ratings reissued a “buy (b)” rating on shares of HCA Healthcare in a report on Friday, March 27th. Deutsche Bank Aktiengesellschaft cut their target price on HCA Healthcare from $558.00 to $540.00 and set a “buy” rating on the stock in a research note on Tuesday, April 28th. Mizuho increased their price objective on shares of HCA Healthcare from $540.00 to $585.00 and gave the stock an “outperform” rating in a report on Wednesday, February 25th. Jefferies Financial Group restated a “buy” rating and issued a $525.00 target price on shares of HCA Healthcare in a research report on Friday, April 24th. Finally, Leerink Partners cut their price target on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Sixteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $517.82.

Insider Activity at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 1,694 shares of the firm’s stock in a transaction on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total transaction of $903,528.78. Following the completion of the sale, the executive vice president directly owned 8,853 shares of the company’s stock, valued at $4,721,924.61. This trade represents a 16.06% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 1.50% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.